| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/24/2005 | EP1566181A1 Novel medicament for ameliorating neurotransmission dysfunction diseases |
| 08/24/2005 | EP1566180A2 Use of GLP-1 or Analogs in Treatment of Myocardial Infarction |
| 08/24/2005 | EP1566177A1 The use of bisphosphonates for treating skin by stimulating of collagen synthesis |
| 08/24/2005 | EP1565571A2 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 08/24/2005 | EP1565552A2 Esm-1 gene differentially expressed in angiogenesis, antagonists thereof, and methods of using the same |
| 08/24/2005 | EP1565489A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/24/2005 | EP1565488A2 Cancer-linked gene as target for chemotherapy |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1565485A1 Perindopril |
| 08/24/2005 | EP1565482A2 A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same |
| 08/24/2005 | EP1565230A2 Material compositions and related systems and methods for treating cardiac conditions |
| 08/24/2005 | EP1565215A2 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 08/24/2005 | EP1565214A2 Treatment of immunological renal disorders by lymphotoxin pathway inhibitors |
| 08/24/2005 | EP1565212A1 Gastrin compositions and formulations, and methods of use and preparation |
| 08/24/2005 | EP1565210A2 Treatment of mammalian reaction to ige interactions |
| 08/24/2005 | EP1565209A2 Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 08/24/2005 | EP1565208A1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 08/24/2005 | EP1565207A2 Prekallikrein depleted plasma derived albumin fraction |
| 08/24/2005 | EP1565205A2 Interferon-alpha polypeptides and conjugates |
| 08/24/2005 | EP1565204A1 Use of fgf-18 in the diagnosis and treatment of memory disorders |
| 08/24/2005 | EP1565203A2 Templated native silk smectic gels |
| 08/24/2005 | EP1565202A2 Methods for the treatment of alzheimer's disease and compositions therefore |
| 08/24/2005 | EP1565201A1 Methods of administering dalbavancin for treatment of bacterial infections |
| 08/24/2005 | EP1565200A2 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565193A2 Methods and compositions for treating cancer using proteasome inhibitors |
| 08/24/2005 | EP1565183A1 Rapamycin and il-10 for the treatment of immune diseases |
| 08/24/2005 | EP1565175A1 Use of a histone deacetylase inhibitor for treating muscular dystrophies |
| 08/24/2005 | EP1565160A2 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 08/24/2005 | EP1565149A1 Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil |
| 08/24/2005 | EP1421104A4 Human zona pellucida proteins and methods of their use in diagnosing male infertility |
| 08/24/2005 | EP1402008B1 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
| 08/24/2005 | EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/24/2005 | EP1356733B1 Pesticidal and antiparasitic compositions |
| 08/24/2005 | EP1246919B1 Progenitor cell preservation factors and related methods and products |
| 08/24/2005 | EP1086122B1 Pyrazinone protease inhibitors |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | EP0955057B1 Human growth hormone as an aid for hypothermia |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | EP0681483B1 Compositions and methods for delivery of genetic material |
| 08/24/2005 | CN1659438A G-protein coupled receptor ligands and methods |
| 08/24/2005 | CN1659436A Method for isolating ligands |
| 08/24/2005 | CN1659288A Method to inhibit cell growth using oligonucleotides |
| 08/24/2005 | CN1659214A Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications |
| 08/24/2005 | CN1659187A Ferritin fusion proteins for use in vaccines and other applications |
| 08/24/2005 | CN1659184A Prothrombin activating protein |
| 08/24/2005 | CN1659183A Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 08/24/2005 | CN1659182A Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 08/24/2005 | CN1659180A Novel recombinant anticoagulant proteins |
| 08/24/2005 | CN1658905A Modified byrodin 1 with reduced immunogenicity |
| 08/24/2005 | CN1658901A Methods for treating TWEAK-related conditions |
| 08/24/2005 | CN1658898A Orodispersible pharmaceutical composition comprising perindopril |
| 08/24/2005 | CN1658897A Methods for treating muscle injuries |
| 08/24/2005 | CN1658896A Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 08/24/2005 | CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 08/24/2005 | CN1658894A Methods and compositions for the treatment of eye diseases |
| 08/24/2005 | CN1658893A G-type peptides to ameliorate atherosclerosis |
| 08/24/2005 | CN1658892A Method for isolating subpopulations of proteins that engage in protein-protein interactions |
| 08/24/2005 | CN1658879A Neurotrophic factor production accelerator |
| 08/24/2005 | CN1658860A Method of inhibiting angiogenesis |
| 08/24/2005 | CN1658767A Composition for modulating a physiological reaction or inducing an immune response |
| 08/24/2005 | CN1658763A Canola protein isolate compositions |
| 08/24/2005 | CN1657626A Antifungal polypeptide and its preparation method |
| 08/24/2005 | CN1657619A Recombination human erythropoietin gene suitable for pronucleus expression system and its expression carrier |
| 08/24/2005 | CN1657616A Preparation method and use of high antiviral active recombination chicken gamma-interferon crCHIFN-gamma |
| 08/24/2005 | CN1657540A Polyethylene glycol derivative of human parathyrin (1-34), medicinal composition containing same and use |
| 08/24/2005 | CN1657539A Human connective tissue growth factor mutant protein and its application |
| 08/24/2005 | CN1657537A Central body located gene and its use in medicinal region |
| 08/24/2005 | CN1657101A Application of liver cells growth factor gene modified myeloid interstitial dry cell in treating mgocardial ischemia |
| 08/24/2005 | CN1657098A Preparation method of earthworm kinase dry powder |
| 08/24/2005 | CN1657097A Action of transfer factor for anti Aids virus |
| 08/24/2005 | CN1216149C Cell strain of expression mutation type human tissue plasminogen activator imethod for construction and preparation method of expressing protein |
| 08/24/2005 | CN1216075C Hepatitis C virus high change region 1 synthetic peptide and its use |
| 08/24/2005 | CN1216073C Bioactive peptide of sepuence No.4 |
| 08/24/2005 | CN1216072C Bioactive peptide of sequence No.5 |
| 08/24/2005 | CN1216071C Bioactive peptide of sequcene No.27 |
| 08/24/2005 | CN1216070C Bioactive peptide sequence No.20 |
| 08/24/2005 | CN1216069C Bioctive peptide of sequence No.25 |
| 08/24/2005 | CN1216068C Bioactive peptide of sequence No.14 |
| 08/24/2005 | CN1216067C Bioactive peptide of sequence No.15 |
| 08/24/2005 | CN1215879C 人类sars冠状病毒受体抑制剂 Human sars coronavirus receptor inhibitors |
| 08/24/2005 | CN1215877C Recombined human interleukin-2 injection and preparing method thereof |
| 08/24/2005 | CN1215832C 气雾剂组合物 Aerosol composition |
| 08/24/2005 | CA2497796A1 Fibrinogen purification |
| 08/23/2005 | US6933422 Nav2 channel gene-deficient mice |
| 08/23/2005 | US6933373 Tumor suppressor protein for as a antiproliferative agent |
| 08/23/2005 | US6933369 Mammalian proteinases; oxidoreductases; related reagents |
| 08/23/2005 | US6933366 Specificity exchangers that redirect antibodies to bacterial adhesion receptors |
| 08/23/2005 | US6933363 Compositions and methods for therapy and diagnosis of lung cancer |
| 08/23/2005 | US6933326 fracturing collagen-containing tissue that is acellular and dehydrated and has a basement membrane to which, after rehydration, viable endothelial and epithelial cells attach |
| 08/23/2005 | US6933303 Antidiabetic agents |
| 08/23/2005 | US6933290 2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives |
| 08/23/2005 | US6933288 Pyranosyl cytosines: pharmaceutical formulations and methods |
| 08/23/2005 | US6933286 Therapeutic delivery compositions and methods of use thereof |
| 08/23/2005 | US6933282 increasing the effective amount of tyrosine hydroxylase (TH) in the central nervous systems (CNS) for the purpose of increasing TH-mediated dopamine production in the treatment of Parkinson's disease |
| 08/23/2005 | US6933281 Administering nonapeptides conjugated to drugs or labels, that preferentially targets the lungs, pancreas, skins, eyes, prostate galnds , ovaries, adrenal gland, liver or alimentary canal; drug delivery; medical diagnosis |
| 08/23/2005 | US6933280 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 08/23/2005 | US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini |
| 08/23/2005 | US6933278 Administering as hypotensive agents, somatotrophins and optionally angiotensin 1-converting enzyme inhibitors, to humans having congenital disorders |
| 08/23/2005 | US6933277 Administering polypeptide mixture |